1-Day Extracellular Vesicle-based Dx & Rx Summit (San Diego, CA, United States – March 28, 2019) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Extracellular
Vesicle-based Dx & Rx Summit”
conference has been added to ResearchAndMarkets.com’s
offering.

Extracellular Vesicles (EVs)-based Diagnostics and Therapeutics Summit
2019 focuses on the emerging field of deploying Exosomes as diagnostics
and the engineering of exosomes and extracellular vesicles as a delivery
tool for therapeutics moieties.

The ability to engineer EVs and the ability of EVs to target specific
sites offers the ability to tailor therapeutics with exquisite targeting
ability and opens up a whole new class of therapeutics which are
classified as biologicals and which do not have the side effects and
toxicity associated with small molecule-based therapies.

This summit explores this topic and takes a deep dive into the
technology platforms, diseases targeted and clinical results-to-date.

This summit is co-located and concurrent with the Circulating Biomarkers
World Congress 2019 and Liquid Biopsies 2019 events providing a 360o
view of the field of exosomes and other circulating biomarker classes
from biomarker/diagnostic potential to therapeutics opportunities in the
future.

Agenda: Thursday, 28 March 2019

10:00 – Conference Chair

  • Conference Chaiperson Opening Remarks
  • Lucia Languino, Professor of Cancer Biology, Thomas Jefferson
    University, United States of America
  • Summit Session Title: Emerging Themes in EV-based Diagnostics and
    Therapeutics
  • Summit Chairpersons: Professor Lucia Languino and Professor Paul
    Robbins

10:30 – Extracellular Vesicles and Aging

  • Paul Robbins, Professor, Department of Biochemistry, Molecular
    Biology, and Biophysics, and the Institute on the Biology of Aging and
    Metabolism, University of Minnesota Medical School, United States of
    America

11:00 – Keynote Presentation

  • Diversity of Extracellular Vesicles to Understand their Diagnostic and
    Therapeutic Potential
  • Jan Ltvall, Professor, University of Gothenburg; Founding President of
    ISEV, Sweden

11:30 – Keynote Presentation

  • Exosome Signaling in Brain Development
  • Hollis Cline, Chair of Neuroscience and Hahn Professor of
    Neuroscience, The Scripps Research Institute, United States of America

12:00 – Networking Lunch in the Exhibit Hall and Poster Viewing

12:30 – Keynote Presentation

  • Plasma Extracellular Vesicles Sub-fractions For Diagnosis of
    Cardiovascular Disease
  • Dominique PV de Kleijn, Professor Experimental Vascular Surgery,
    Professor Netherlands Heart Institute, University Medical Center
    Utrecht, The Netherlands, Netherlands

13:00 – EV Isolation from Biofluids

  • Shannon Pendergrast, Chief Scientific Officer, Ymir Genomics
  • We will present several novel products and methods for the rapid and
    effective isolation of biofluid extracellular vesicles (EVs).

13:30 – Keynote Presentation

  • Exosome Engineering for Delivery of Cytosolic Proteins: Principles and
    Therapeutic Applications
  • Chulhee Choi, Professor and Chair, BioMedical Imaging Center, Korea
    Advanced Institute of Science and Technology (KAIST), President,
    Cellex Life Sciences, Korea South

14:00 – Induced Tissue Regeneration (iTR) Using Extracellular
Vesicles

  • Dana Larocca, VP Discovery Research, AgeX Therapeutics, United States
    of America

14:30 – Adipose-derived Stem Cell Extracellular Vesicles can be
Specifically Tuned for Soft Tissue Repair and Wound Healing

  • John Ludlow, Executive Director, Regenerative Medicine, Zen-Bio, Inc.,
    United States of America
  • Our research program is designed to provide critical proof-of-concept
    data demonstrating manufacturing conditions and wound healing
    properties of stem cell-derived extracellular vesicles.

15:00 – The HSP-Accessorized Exosome: Presence in States of
Danger, Disease, and Disruption

  • Michael Graner, Associate Professor, Dept of Neurosurgery, University
    of Colorado Anschutz School of Medicine, United States of America

15:30 – Human Liver Stem Cell-derived Nano-EVs – A Broad
Platform Technology for Cancer and Regeneration

  • Daniel Gau, Head of Business Development, Unicyte AG, Germany

16:00 – Cell-to-Cell Propagation of Pathogenic Aberrant
Dipeptide Repeat Proteins in C9orf72-Linked Amyotrophic Lateral Sclerosis

  • Davide Trotti, Professor, Scientific Director, Weinberg ALS Center,
    Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson
    University, United States of America

16:30 – NanoView BiosciencesRoutine Single EV Protein Biomarker
Analysis

  • Clayton Deighan, Regional Sales Director, NanoView Biosciences

17:00 – Extracellular Vesicles Go Nuclear

  • Aurelio Lorico, Professor of Pathology, Touro University Nevada,
    United States of America

17:30 – Industry Panel Discussion Focusing on Circulating
Biomarkers & Liquid Biopsy

For more information about this conference visit https://www.researchandmarkets.com/research/xrjk26/1day?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Genomics

error: Content is protected !!